Health News

Waging War Against Chronic Myeloid Leukemia
A possible new front runner is emerging in the drug war against chronic myeloid leukemia ( CML ). While still considered experimental, this drug is showing itself to be a powerful agent against advanced forms of the disease.
Unlocking Chronic Myeloid Leukemia Resistance
Gleevec ( imatinib ) has transformed the treatment of chronic myeloid leukemia ( CML ). The problem is, this drug stops working at some point in many patients. A drug under development, combined with another currently available medication, may offer patients new options.
Which is Better for Chronic Myeloid Leukemia?
Chronic Myeloid Leukemia ( CML ) has some amazing treatment options for patients. The disease has proven to respond well to three drugs known as tyrosine kinase inhibitors. An ongoing trial is looking to see which of two of these drugs is most effective.
Improving Chronic Myeloid Leukemia Treatment
Since its introduction some years ago, Gleevec ( imatinib ) has been the drug of choice for treating patients newly diagnosed with chronic myeloid leukemia ( CML ).
Expanding Chronic Myeloid Leukemia Options
Research into more effective treatments for chronic myeloid leukemia is opening up all sorts of possibilities. Drugs are being combined, new drugs are being developed and there is even work involving a possible vaccine.
Chronic Myeloid Leukemia Advancements
The outlook for people with chronic myeloid leukemia has improved by leaps and bounds in recent years. A number of medications are now keeping the disease under wraps.
Some Drugs are Easier to Stick with Than Others
So you have to take a pill every day. It's saving your life, but doing anything every single day for the rest of your life is daunting. Recent research looked at which medications leukemia patients take more faithfully.
Drug Offers Cancer Patients a Normal Life
For some patients, living with chronic myelogenous leukemia ( CML ) isn't terribly difficult; it just means taking a single pill once a day and living normal life.
When One Drug Doesn't Work Another One Does
The medication Gleevec ( imatinib ) remains the standard of care for people newly diagnosed with chronic myeloid leukemia ( CML ). But not all patients respond well to this medicine, and now they have an alternative.
New Therapy for Leukemia in the Works
Chronic myeloid leukemia ( CML ) results when the growth of white blood cells goes berserk and too many are produced in the bone marrow. A new method to treat this disease is being studied.